Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer
Clinical trial NCT05076851 · UNKNOWN
Trial details
- NCT number
- NCT05076851
- Sponsor
- Hongqian Guo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-17
- Primary completion
- 2021-12-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.